Skip to main content
Log in

Urinary biomarkers of exposure to the mycoestrogen zearalenone and its modified forms in German adults

  • Biologics
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Zearalenone (ZEN), a mycotoxin with estrogenic activity, can exert adverse endocrine effects in mammals and is thus of concern for humans. ZEN is found in cereal crops and grain-based foods, often along with modified (‘masked’) forms usually not detected in routine contaminant analysis, e.g., ZEN-O-β-glucosides and ZEN-14-sulfate. These contribute to mycoestrogen exposure, as they are cleaved in the gastrointestinal tract to ZEN, and further metabolized in animals and humans to α- and β-zearalenol (α-ZEL and β-ZEL). ZEN and its metabolites are mainly excreted as conjugates in urine, allowing to monitor human exposure by a biomarker-based approach. Here, we report on a new study in German adults (n = 60) where ZEN, α-ZEL, and β-ZEL were determined by LC-MS/MS analysis after enzymatic hydrolysis and immunoaffinity column clean-up of the aglycones in urines. Biomarkers were detected in all samples: ZEN ranges 0.04–0.28 (mean 0.10 ± 0.05; median 0.07) ng/mL; α-ZEL ranges 0.06–0.45 (mean 0.16 ± 0.07; median 0.13) ng/mL, and β-ZEL ranges 0.01–0.20 (mean 0.05 ± 0.04; median 0.03) ng/mL. Notably, average urinary levels of α-ZEL, the more potent estrogenic metabolite, are higher than those of ZEN, while β-ZEL (less estrogenic than ZEN) is found at lower levels than the parent mycotoxin. Similar results were found in ten persons who collected multiple urine samples to gain more insight into temporal fluctuations in ZEN biomarker levels; here some urines had higher maximal concentrations of total ZEN (the sum of ZEN, α-ZEL, and β-ZEL) with 1.6 and 1.01 ng/mL, i.e., more than those found in the majority of other urines. A preliminary approach to translate the new urinary biomarker data into dietary mycotoxin intake suggests that exposure of most individuals in our cohort is probably below the tolerable daily intake (TDI) of 0.25 µg/kg b.w. set by EFSA as group value for ZEN and its modified forms while that of some individuals exceed it. In conclusion, biomonitoring can help to assess consumer exposure to the estrogenic mycotoxin ZEN and its modified forms and to identify persons at higher risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Notes

  1. Composed of factor 4 for interspecies extrapolation in kinetics and factor 10 for interhuman variability.

  2. Several phase II metabolites from mammalian metabolism and ‘masked’ forms produced by plants or fungi.

Abbreviations

ZEN:

Zearalenone

α-ZEL:

Alpha-zearalenol

β-ZEL:

Beta-zearalenol

References

  • Ali N, Blaszkewicz M, Degen GH (2015) Occurrence of the mycotoxin citrinin and its metabolite dihydrocitrinone in urines of German adults. Arch Toxicol 89(4):573–578

    Article  CAS  Google Scholar 

  • Ali N, Blaszkewicz M, Degen GH (2016) Assessment of deoxynivalenol exposure among Bangladeshi and German adults by a biomarker-based approach. Toxicol Lett 258:20–28

    Article  CAS  Google Scholar 

  • Berthiller F, Crews C, Dall’Asta C, Saeger SD, Haesaert G, Karlovsky P, Oswald IP, Seefelder W, Speijers G, Stroka J (2013) Masked mycotoxins: a review. Mol Nutr Food Res 57:165–186

    Article  CAS  Google Scholar 

  • Binder SB, Schwartz-Zimmermann HE, Varga E, Bichl G, Michlmayr H, Adam G, Berthiller F (2017) Metabolism of zearalenone and its major modified forms in pigs. Toxins 9:56. https://doi.org/10.3390/toxins9020056

    Article  CAS  PubMed Central  Google Scholar 

  • Blaszkewicz M, Liesenhoff-Henze K (2012) Creatinine in urine [Biomonitoring Methods, 2010]. The MAK collection for occupational health and safety. Wiley VCH, Weinheim, pp 169–184. https://doi.org/10.1002/3527600418.bi6027urie0012

    Book  Google Scholar 

  • Bolt HM, Janning P, Michna H, Degen GH (2001) Comparative assessment of endocrine modulators with oestrogenic activity. I. Definition of a hygiene-based margin of safety (HBMOS) for xenooestrogens against the background of European developments. Arch Toxicol 74:649–662

    Article  CAS  Google Scholar 

  • Choi J, Mørck TA, Polcher A, Knudsen LE, Joas A (2015) Review of the state of the art of human biomonitoring for chemical substances and its application to human exposure assessment for food safety. In: EFSA (ed) EFSA supporting publication 2015: EN-724, p 321. https://doi.org/10.2903/sp.efsa.2015.EN-724

  • De Boeuvre M, Jacxsens L, Lachat C, Eeckhout M, Di Mavungu JD, Audenaert K, Maene P, Haesaert G, Kolsteren P, De Meulenaer B, De Saeger S (2013) Human exposure to mycotoxins and their masked forms through cereal-based foods in Belgium. Toxicol Lett 218:281–292

    Article  Google Scholar 

  • Degen GH (2004) Endokrine disruptoren in lebensmitteln. Bundesgesundheitsblatt 47:848–857

    CAS  Google Scholar 

  • Degen GH (2017) Mykotoxine in Lebensmitteln—Vorkommen, Bedeutung und gesundheitliches Risiko. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 60(7):745–756

    Article  Google Scholar 

  • Döll S, Dänicke S, Ueberschär KH, Valenta H, Schnurrbusch U, Ganter M, Klobasa F, Flachowsky G (2003) Effects of graded levels of Fusarium toxin contaminated maize in diets for female weaned piglets. Arch Tierernährung 57:311–334

    Google Scholar 

  • EFSA Panel on Contaminants in the Food Chain (2011) Scientific opinion on the risks for public health related to the presence of zearalenone in food. EFSA J 9(6):2197. https://doi.org/10.2903/j.efsa.2011.2197 (124 pp)

    Article  CAS  Google Scholar 

  • EFSA Panel on Contaminants in the Food Chain (2014) Scientific Opinion on the risks for human and animal health related to the presence of modified forms of certain mycotoxins in food and feed. EFSA J 12:3916. https://doi.org/10.2903/j.efsa.2014.3916 (60 pp)

    Article  CAS  Google Scholar 

  • EFSA Panel on Contaminants in the Food Chain (2016) Scientific opinion on the appropriateness to set a group health-based guidance value for zearalenone and its modified forms. EFSA J 14(4):4425. https://doi.org/10.2903/j.efsa.2016.4425 (46 pp)

    Article  CAS  Google Scholar 

  • Ezekiel CN, Warth B, Ogara IM, Abia WA, Ezekiel VC et al (2014) Mycotoxin exposure in rural residents in Northern Nigeria: a pilot study using multi-urinary biomarkers. Environ Int 66:138–145

    Article  CAS  Google Scholar 

  • Fink-Gremmels J, Malekinejad H (2007) Clinical effects and biochemical mechanisms associated with exposure to the mycoestrogens zearalenone. Animal Feed Sci Technol 137:326–341

    Article  CAS  Google Scholar 

  • Föllmann W, Ali N, Blaszkewicz M, Degen G (2016) Biomonitoring of mycotoxins in urine: pilot study in mill workers. J Toxicol Environ Health A 79(22–23):1015–1025

    Article  Google Scholar 

  • Gajęcka M, Rybarczyk L, Jakimiuk E, Zielonka Ł, Obremski K, Zwierzchowski W, Gajęcki M (2012) The effect of experimental long-term exposure to low-dose zearalenone on uterine histology in sexually immature gilts. Exp Toxicol Pathol 64(6):537–542

    Article  Google Scholar 

  • Gareis M, Bauer J, Thiem J, Plank G, Grabley S, Gedek B (1990) Cleavage of zearalenone-glycoside, a “masked” mycotoxin, during digestion in swine. Zentralbl Veterinärmed B 37(3):236–240

    CAS  PubMed  Google Scholar 

  • Gerding J, Ali N, Schwartzbord J, Cramer B, Brown DL, Degen GH, Humpf HU (2015) A comparative study of the human urinary mycotoxin excretion patterns in Bangladesh, Germany and Haiti using a rapid and sensitive LC–MS/MS approach. Mycotoxin Res 31:127–136

    Article  CAS  Google Scholar 

  • Kommission Humanbiomonitoring des Umweltbundesamtes (2005) Normierung von Stoffgehalten in Urin–Kreatinin. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 48:616–618

    Article  Google Scholar 

  • Mally A, Solfrizzo M, Degen GH (2016) Biomonitoring of the mycotoxin zearalenone: current state-of-the art and application to human exposure assessment. Arch Toxicol 90:1281–1292

    Article  CAS  Google Scholar 

  • Maragos C (2010) Zearalenone occurrence and human exposure. World Mycotoxin J 3:369–383

    Article  CAS  Google Scholar 

  • Metzler M, Pfeiffer E, Hildebrand A (2010) Zearalenone and its metabolites as endocrine disrupting chemicals (EDC). World Mycotoxin J 3:385–401

    Article  CAS  Google Scholar 

  • Mirocha CJ, Pathre SV, Robison TS (1981) Comparative metabolism of zearalenone and transmission into bovine milk. Food Cosmet Toxicol 19:25–30

    Article  CAS  Google Scholar 

  • Ogden TL (2010) Handling results below the level of detection. Ann Occup Hyg 54:255–256

    CAS  PubMed  Google Scholar 

  • Rychlik M, Humpf HU, Marko D, Dänicke S, Mally A, Berthiller F, Klaffke H, Lorenz N (2014) Proposal of a comprehensive definition of modified and other forms of mycotoxins including “masked” mycotoxins. Mycotoxin Res 30:197–205

    Article  CAS  Google Scholar 

  • Sarkanj B, Ezekiel CN, Turner PC, Abia WA, Rychlik M, Krska R, Warth B (2018) Ultra-sensitive, stable isotope assisted quantification of urinary mycotoxin exposure biomarkers. Anal Chim Acta 1019:84–92

    Article  CAS  Google Scholar 

  • Shephard GS, Burger HM, Gambacorta L, Gong YY, Krska R, Rheeder JP, Solfrizzo M, Srey C, Sulyok M, Visconti A, Warth B, van der Westhuizen L (2013) Multiple mycotoxin exposure determined by urinary biomarkers in rural subsistence farmers in the former Transkei, South Africa. Food Chem Toxicol 62:217–225

    Article  CAS  Google Scholar 

  • Solfrizzo M, Gambacorta L, Visconti A (2014) Assessment of multimycotoxin exposure in southern Italy by urinary multi-biomarker determination. Toxins (Basel) 6:523–538

    Article  Google Scholar 

  • Wallin S, Gambacorta L, Kotova N, Lemming EW, Nalsen C, Solfrizzo M, Olsen M (2015) Biomonitoring of concurrent mycotoxin exposure among adults in Sweden through urinary multibiomarker analysis. Food Chem Toxicol 83:133–139

    Article  CAS  Google Scholar 

  • Warth B, Sulyok M, Berthiller F, Schuhmacher R, Krska R (2013) New insights into the human metabolism of the Fusarium mycotoxins deoxynivalenol and zearalenone. Toxicol Lett 220:88–94

    Article  CAS  Google Scholar 

  • Zinedine A, Soriano JM, Molto JC, Manes J (2007) Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food Chem Toxicol 45:1–18

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors are grateful to all volunteers who participated in this study, and wish to thank Dr. Meinolf Blaszkewicz and Iris Glaeser from the IfADo Central Unit Analytical Chemistry for valuable technical support. This work was supported by a full scholarship from the Deutsche Akademische Auslandsdienst (DAAD) to Nurshad Ali.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gisela H. Degen.

Ethics declarations

Conflict of interest

None of the authors have any conflict of interest to declare.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 19 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ali, N., Degen, G.H. Urinary biomarkers of exposure to the mycoestrogen zearalenone and its modified forms in German adults. Arch Toxicol 92, 2691–2700 (2018). https://doi.org/10.1007/s00204-018-2261-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-018-2261-5

Keywords

Navigation